OKYO — OKYO Pharma Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall Cap

Annual balance sheet for OKYO Pharma, fiscal year end - March 31st, GBP millions except per share, conversion factor applied.

	2018 March 31st	2019 March 31st	2020 March 31st	2021 March 31st	2022 March 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	2.01	0.481	0.19	4.99	2.06
Net Total Accounts Receivable
Net Total Receivables	0	0.085	0.263	0.055	0.672
Prepaid Expenses
Total Current Assets	2.01	0.582	0.458	5.06	3.27
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0	0.001	0.025	0.076	0.004
Total Assets	2.01	0.583	0.483	5.14	3.27
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	0.091	0.327	0.575	1.24	1.03
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Liabilities	0.091	0.327	0.596	1.28	1.03
Common Stock
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	1.92	0.255	-0.113	3.85	2.24
Total Liabilities & Shareholders' Equity	2.01	0.583	0.483	5.14	3.27
Total Common Shares Outstanding